Vessel Co-option in Primary Human Tumors and Metastases: an Obstacle to Effective Anti-angiogenic Treatment
Expected timeline: Week 1-4: Inflammation reduction, potential nerve symptom improvement Week 4-8: Progressive healing, reduced radicular symptoms Week 8-12: Structural improvements developing, continued symptom reduction Week 12-16: Consolidation of gains, assessment for continued protocol Important notes: Disc herniations vary enormously in severity
Integration with broader metabolic protocol DSIP is rarely, if ever, a standalone intervention
5-Amino-1MQ Animal Studies Studies using 5-Amino-1MQ specifically have demonstrated its potency and selectivity as an NNMT inhibitor, with IC50 values in the low micromolar range and good selectivity over other methyltransferases
What researchers measure In controlled environments, researchers track variables individually: concentration, solvent choice, reconstitution amount, aliquots, and degradation rate
Nicotinamide Preservation 5-Amino-1MQ functions as a NAM-site competitive inhibitor, binding at the active site of NNMT and preventing the enzyme from methylating nicotinamide
